NeuroBo Pharmaceuticals, Inc

$3.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.53%) Today
-$0.07 (-1.85%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NRBO and other stocks, options, and ETFs commission-free!

About NRBO

NeuroBo Pharmaceuticals, Inc. Common Stock, also called NeuroBo Pharmaceuticals, Inc, is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

CEO
Jeong Gu Kang
Employees
12
Headquarters
Boston, Massachusetts
Founded
2014
Market Cap
87.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
115.05K
High Today
$3.87
Low Today
$3.65
Open Price
$3.79
Volume
135.07K
52 Week High
$29.49
52 Week Low
$3.63

NRBO Earnings

-$3.37
-$2.25
-$1.12
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17, Pre-Market

You May Also Like

FNDX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure